Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico study

9 Aug 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to SARS-CoV-2 and COVID-19 Research
Share to Synthesis and biological activity

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34399157
DOI: 10.1016/j.mehy.2021.110656

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studyPMID 34399157Read ↗

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approachSemantic proximity Read ↗

Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?Semantic proximity Read ↗

Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studiesSemantic proximity Read ↗

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read ↗

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease InhibitorsSemantic proximity Read ↗

An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity Read ↗

Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity Read ↗

Safeguarding COVID-19 and cancer management: drug design and therapeutic approachSemantic proximity Read ↗

Small molecules in the treatment of COVID-19Semantic proximity Read ↗

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read ↗

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic DataSemantic proximity Read ↗

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.